Curex Life Science Fund, LP — Form D/A

Curex Life Science Fund, LP of NASHVILLE, TN, a pooled investment fund, filed a Form D amendment with the SEC on 2021-12-13. $9.2M was reported sold. Industry: Pooled Investment Fund.

Offering

• Filed: 2021-12-13
• Form: D/A
• Accession: 0001789886-21-000001
• Industry: Pooled Investment Fund
• Exemptions: 06b, 3C, 3C.1
• Amount sold: $9.2M
• Investors: 30
• Date of first sale: 2019-12-03
• Security types: equity, fund interests
• SEC file number: 021-355687

Issuer

• Name: Curex Life Science Fund, LP
• CIK: 0001789886
• Entity type: Limited Partnership
• Jurisdiction: DELAWARE
• Incorporated: 2019
• Address: 8200 HWY 100, NASHVILLE, TN, 37221
• Phone: 615-498-1887

Officers, directors & promoters (5)

Other filings by this issuer (6)

More

• CIK 1789886 on SEC EDGAR (source of record)
• This page as markdown (for LLM agents)
• Search all SEC filings, advisers and people on Adviser Search